Eps Summary of Camurus AB (publ)

Camurus AB (publ)'s latest annual eps in 2023 was 7.50 SEK , up 670.3% from previous year.
Camurus AB (publ)'s latest quarterly eps in 2024 Q2 was 1.28 SEK , down -8.09% from previous quarter.
Camurus AB (publ) reported an annual eps of 1.01 SEK in 2022, up 160.84% from previous year.
Camurus AB (publ) reported an annual eps of -1.66 SEK in 2021, up 47.8% from previous year.
Camurus AB (publ) reported a quarterly eps of 1.36 SEK for 2024 Q1, up 603.7% from previous quarter.
Camurus AB (publ) reported a quarterly eps of 1.56 SEK for 2023 Q3, down -71.32% from previous quarter.

Annual Eps Chart of Camurus AB (publ) (2023 - 2012)

Historical Annual Eps of Camurus AB (publ) (2023 - 2012)

Year	Eps	Eps Growth
2023	7.50 SEK	670.3%
2022	1.01 SEK	160.84%
2021	-1.66 SEK	47.8%
2020	-3.18 SEK	48.96%
2019	-6.23 SEK	-7.97%
2018	-5.77 SEK	-23.29%
2017	-4.68 SEK	-135.18%
2016	-1.99 SEK	63.88%
2015	-5.51 SEK	-566.95%
2014	1.18 SEK	-51.44%
2013	2.43 SEK	636.36%
2012	0.33 SEK	0.0%

Year	Eps	Eps Growth
2024 Q2	1.28 SEK	-8.09%
2024 Q1	1.36 SEK	603.7%
2023 Q3	1.56 SEK	-71.32%
2023 FY	- SEK	670.3%
2023 Q4	-0.27 SEK	-117.31%
2023 Q2	5.44 SEK	413.21%
2023 Q1	1.06 SEK	341.67%
2022 Q1	-0.01 SEK	94.73%
2022 FY	- SEK	160.84%
2022 Q3	0.63 SEK	320.0%
2022 Q4	0.24 SEK	-61.9%
2022 Q2	0.15 SEK	1194.89%
2021 Q3	-0.11 SEK	87.64%
2021 Q4	-0.26 SEK	-136.36%
2021 FY	- SEK	47.8%
2021 Q1	-0.40 SEK	67.21%
2021 Q2	-0.89 SEK	-122.5%
2020 Q1	-1.19 SEK	19.05%
2020 FY	- SEK	48.96%
2020 Q4	-1.22 SEK	-221.05%
2020 Q3	-0.38 SEK	2.56%
2020 Q2	-0.39 SEK	67.23%
2019 Q4	-1.47 SEK	-12.21%
2019 Q1	-1.62 SEK	36.22%
2019 Q2	-1.70 SEK	-4.94%
2019 Q3	-1.31 SEK	22.94%
2019 FY	- SEK	-7.97%
2018 Q2	-1.81 SEK	-86.6%
2018 FY	- SEK	-23.29%
2018 Q4	-2.54 SEK	-122.81%
2018 Q3	-1.14 SEK	37.02%
2018 Q1	-0.97 SEK	30.71%
2017 FY	- SEK	-135.18%
2017 Q3	-1.29 SEK	-15.18%
2017 Q4	-1.40 SEK	-8.53%
2017 Q1	-0.99 SEK	-32.0%
2017 Q2	-1.12 SEK	-13.13%
2016 Q1	-0.48 SEK	54.29%
2016 FY	- SEK	63.88%
2016 Q3	-0.32 SEK	36.0%
2016 Q4	-0.75 SEK	-134.38%
2016 Q2	-0.50 SEK	-4.17%
2015 Q2	-4.18 SEK	-1200.0%
2015 Q1	0.38 SEK	-87.9%
2015 Q3	-0.56 SEK	86.6%
2015 Q4	-1.05 SEK	-87.5%
2015 FY	- SEK	-566.95%
2014 Q4	3.14 SEK	8363.16%
2014 Q3	-0.04 SEK	0.0%
2014 FY	- SEK	-51.44%
2013 FY	- SEK	636.36%
2012 FY	- SEK	0.0%

Peer Eps Comparison of Camurus AB (publ)

Name	Eps	Eps Difference
ContraFect Corporation	-124.97 USD	106.001%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	114.77%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	14663.107%
SQZ Biotechnologies Company	-2.76 USD	371.739%
Intellipharmaceutics International Inc.	-0.09 USD	8681.236%
Evofem Biosciences, Inc.	10.35 USD	27.536%
Santhera Pharmaceuticals Holding AG	5.95 USD	-26.05%
Propanc Biopharma, Inc.	-0.02 USD	31745.57%
Marizyme, Inc.	-1.44 USD	620.833%
Genus plc	0.12 USD	-6150.0%
Pharming Group N.V.	-0.02 USD	46683.851%
Therapeutic Solutions International, Inc.	-0.00 USD	1071528.571%
CNBX Pharmaceuticals Inc.	-0.42 USD	1885.714%
Nymox Pharmaceutical Corporation	-0.10 USD	7872.021%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	62600.0%
IMV Inc.	-4.37 USD	271.625%
AXIM Biotechnologies, Inc.	-0.04 USD	21286.441%
ONE Bio Corp.	1.43 USD	-424.476%
RVL Pharmaceuticals plc	-0.58 USD	1393.103%
Neon Bloom, Inc.	-0.00 USD	500100.0%
Mosaic ImmunoEngineering Inc.	-0.33 USD	2372.727%
Biomind Labs Inc.	-0.02 USD	46396.296%
American Oriental Bioengineering, Inc.	-781.24 USD	100.96%
Oncotelic Therapeutics, Inc.	-0.02 USD	37788.442%
Skye Bioscience, Inc.	-5.37 USD	239.665%
GlobeStar Therapeutics Corporation	-0.00 USD	312600.0%
Mesoblast Limited	-0.09 USD	8517.508%
THC Farmaceuticals, Inc.	-0.00 USD	937600.0%
Arch Therapeutics, Inc.	-2.27 USD	430.396%
Acro Biomedical Co., Ltd.	-0.26 USD	2984.615%
Curative Biotechnology, Inc.	-0.01 USD	85327.273%
GB Sciences, Inc.	-0.00 USD	183026.829%
MultiCell Technologies, Inc.	-0.00 USD	7500100.0%
Alpha Cognition Inc.	-0.15 USD	5100.0%
HST Global, Inc.	-0.03 USD	26981.72%
CSL Limited	2.73 USD	-174.725%
Arno Therapeutics, Inc.	- USD	-Infinity%
Agentix Corp.	-0.04 USD	21528.571%
Halberd Corporation	-0.00 USD	7500100.0%
Enzolytics Inc.	-0.00 USD	1071528.571%
Resverlogix Corp.	-0.01 USD	52916.901%
Nuo Therapeutics, Inc.	-0.08 USD	10046.95%
argenx SE	-5.16 USD	245.349%
Enzon Pharmaceuticals, Inc.	0.00 USD	-576823.077%
Emmaus Life Sciences, Inc.	-0.07 USD	10768.563%
Inhibitor Therapeutics, Inc.	-0.02 USD	37600.0%
Bioxytran, Inc.	-0.03 USD	23610.972%
Zenith Capital Corp.	-0.07 USD	10829.614%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	298.939%
WPD Pharmaceuticals Inc.	-0.00 USD	1500100.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	8314.677%
GlobeImmune, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Genscript Biotech Corporation	-0.05 USD	16619.824%
Kadimastem Ltd	-0.78 USD	1061.538%
Helix BioMedix, Inc.	-4.70 USD	259.574%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	101451.351%
Capstone Therapeutics Corp.	-36.39 USD	120.61%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	421.888%
PsyBio Therapeutics Corp.	-0.04 USD	17957.143%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Accustem Sciences Inc.	-0.34 USD	2305.882%
EV Biologics, Inc.	-0.12 USD	6350.0%
Reve Technologies, Inc.	-0.01 USD	63125.21%
Q BioMed Inc.	-0.08 USD	9703.073%
LadRx Corporation	0.68 USD	-1002.941%
Cell Source, Inc.	-0.17 USD	4511.765%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
ProtoKinetix, Incorporated	-0.01 USD	75100.0%
Regen BioPharma, Inc.	0.29 USD	-2486.207%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	-0.06 USD	13143.478%
Itoco Inc.	-0.01 USD	98784.211%
Rasna Therapeutics, Inc.	-0.01 USD	75100.0%
Wesana Health Holdings Inc.	-0.05 USD	15070.06%
Endonovo Therapeutics, Inc.	0.03 USD	-29780.478%
Pathfinder Cell Therapy, Inc.	-0.00 USD	300100.0%
RespireRx Pharmaceuticals Inc.	-0.04 USD	21108.403%
GeneThera, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	-0.05 USD	14014.657%
Ember Therapeutics, Inc.	-0.01 USD	119147.619%
NovAccess Global Inc.	-0.23 USD	3360.87%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	1500100.0%
BioStem Technologies, Inc.	-0.62 USD	1309.677%
NanoSphere Health Sciences Inc.	-0.02 USD	33883.784%
Burzynski Research Institute, Inc.	-0.01 USD	73629.412%
Qrons Inc.	-0.06 USD	12964.494%
Alseres Pharmaceuticals, Inc.	-153.67 USD	104.881%
SYBLEU INC	-0.02 USD	42957.143%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	-0.01 USD	56070.149%
Rebus Holdings, Inc.	-0.03 USD	23464.486%
Regen BioPharma, Inc.	0.26 USD	-2784.615%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	52916.901%
Affymax, Inc.	-0.39 USD	2023.077%
Mobile Lads Corp.	-0.01 USD	134028.571%
International Stem Cell Corporation	-0.02 USD	45831.707%
CytoDyn Inc.	-0.05 USD	14277.694%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	-0.00 USD	7500100.0%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	-7.99 USD	193.867%
Adhera Therapeutics, Inc.	-1.18 USD	735.593%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	-0.03 USD	22158.824%
Innovation Pharmaceuticals Inc.	-0.01 USD	119147.619%
Neutra Corp.	-0.00 USD	7500100.0%
Windtree Therapeutics, Inc.	-94.23 USD	107.959%
PureTech Health plc	-2.38 USD	415.126%
Coeptis Therapeutics, Inc.	-0.83 USD	1003.614%
IXICO plc	-0.02 USD	30837.705%
IntelGenx Technologies Corp.	-0.06 USD	13304.225%
Gelesis Holdings, Inc.	-1.35 USD	655.556%
CSL Limited	5.47 USD	-37.112%
Cellectis S.A.	-1.77 USD	523.729%

Global Stocks Search

Camurus AB (publ) (CAMRF)

Eps Summary of Camurus AB (publ)

Annual Eps Chart of Camurus AB (publ) (2023 - 2012)

Historical Annual Eps of Camurus AB (publ) (2023 - 2012)

Peer Eps Comparison of Camurus AB (publ)